Cargando…

The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review

Interferon-beta (IFN-β) for Multiple Sclerosis (MS) is turning 30. The COVID-19 pandemic rejuvenated the interest in interferon biology in health and disease, opening translational opportunities beyond neuroinflammation. The antiviral properties of this molecule are in accord with the hypothesis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellucci, Gianmarco, Albanese, Angela, Rizzi, Caterina, Rinaldi, Virginia, Salvetti, Marco, Ristori, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275407/ https://www.ncbi.nlm.nih.gov/pubmed/37334371 http://dx.doi.org/10.3389/fimmu.2023.1161849

Ejemplares similares

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022)

A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
por: Angeloni, Benedetta, et al.
Publicado: (2021)

Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
por: Severa, Martina, et al.
Publicado: (2020)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
por: Mechelli, Rosella, et al.
Publicado: (2020)

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets
por: Bellucci, Gianmarco, et al.
Publicado: (2020)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCV
por: Laidlaw, Stephen M., et al.
Publicado: (2014)

The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011)

Interferon Lambda Genetics and Biology in Regulation of Viral Control
por: Hemann, Emily A., et al.
Publicado: (2017)

Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
por: Buscarinu, Maria Chiara, et al.
Publicado: (2022)

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
por: Dunn, Nicky, et al.
Publicado: (2020)

Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint
por: Alborghetti, Marika, et al.
Publicado: (2022)

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2020)

Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections
por: Lee, Sanghyun, et al.
Publicado: (2017)

Emerging role for interferons in respiratory viral infections and childhood asthma
por: Bosco, Anthony
Publicado: (2023)

Editorial: Interferon signaling in viral pathogenesis of digestive and respiratory tract
por: Wan, Pin, et al.
Publicado: (2023)

T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination
por: Rosendahl Huber, Sietske, et al.
Publicado: (2014)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Arellano, Gabriel, et al.
Publicado: (2015)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients
por: D’Angelo, Chiara, et al.
Publicado: (2018)

All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes
por: Yang, Emily, et al.
Publicado: (2020)

Editorial: Type 1 interferon in pathologies, autoimmune diseases, and chronic viral infections: understanding the fascinating biologic role of type 1 interferons
por: Herbeuval, Jean-Philippe
Publicado: (2023)

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment
por: Devi-Marulkar, Priyanka, et al.
Publicado: (2021)

Opportunities and Challenges of Extracting Values in Autobiographical Narratives
por: Fischer, Ronald, et al.
Publicado: (2022)

Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis
por: An, Ni, et al.
Publicado: (2022)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2020)

Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
por: Murira, Armstrong, et al.
Publicado: (2016)

Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections
por: Lee, Amos C., et al.
Publicado: (2021)

Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells
por: Lee, Sang Hag, et al.
Publicado: (2023)

Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain
por: Gargano, Francesca, et al.
Publicado: (2022)

Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2023)

Evolution of Interferons and Interferon Receptors
por: Secombes, Chris J., et al.
Publicado: (2017)

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
por: Sugrue, Jamie A., et al.
Publicado: (2021)

Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases
por: Lang, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dcdn82j1gkbit4ncauua3raegm